CNBX Pharmaceuticals CNBX Stock
CNBX Pharmaceuticals Price Chart
CNBX Pharmaceuticals CNBX Financial and Trading Overview
| CNBX Pharmaceuticals stock price | 0.0042 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.01 - 5.5 USD |
| Volume | 19.42K USD |
| Avg. Volume | 791.99K USD |
| Market Cap | 97.34K USD |
| Beta (5Y Monthly) | 1.448591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNBX Valuation Measures
| Enterprise Value | 1.59M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.037 |
Trading Information
CNBX Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.448591 |
| 52-Week Change | -99.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.5 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 1.62 USD |
CNBX Share Statistics
| Avg. Volume (3 month) | 791.99K USD |
| Avg. Daily Volume (10-Days) | 401.98K USD |
| Shares Outstanding | 4.97M |
| Float | 4.19M |
| Short Ratio | N/A |
| % Held by Insiders | 14.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:120 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -133.61% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1530469 USD |
| Net Income Avi to Common (ttm) | -4143349 USD |
| Diluted EPS (ttm) | -2.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 47.75K USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 1.54M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.044 |
| Book Value Per Share (mrq) | -0.91 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -639317 USD |
| Levered Free Cash Flow (ttm) | -1338 USD |
Profile of CNBX Pharmaceuticals
| Country | United States |
| State | MD |
| City | Bethesda |
| Address | #3 Bethesda Metro Center |
| ZIP | 20814 |
| Phone | 877 424 2429 |
| Website | https://www.cnbxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.
Q&A For CNBX Pharmaceuticals Stock
What is a current CNBX stock price?
CNBX Pharmaceuticals CNBX stock price today per share is 0.0042 USD.
How to purchase CNBX Pharmaceuticals stock?
You can buy CNBX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CNBX Pharmaceuticals?
The stock symbol or ticker of CNBX Pharmaceuticals is CNBX.
Which industry does the CNBX Pharmaceuticals company belong to?
The CNBX Pharmaceuticals industry is Biotechnology.
How many shares does CNBX Pharmaceuticals have in circulation?
The max supply of CNBX Pharmaceuticals shares is 33.86M.
What is CNBX Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
CNBX Pharmaceuticals PE Ratio is now.
What was CNBX Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
CNBX Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the CNBX Pharmaceuticals company belong to?
The CNBX Pharmaceuticals sector is Healthcare.